Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c

Bioorganic & Medicinal Chemistry
2016.0

Abstract

A derivative of the staurosporine aglycon (K252c), in which the lactam ring was replaced by a pyrazole moiety, was synthesized. The resulting indolopyrazolocarbazole (3) inhibited Pim isoforms 1-3 whereas it did not impair the activity of two known targets of K252c, protein kinase C isoforms α and γ. Compound 3 exhibited moderate cytotoxic activity toward human leukemia and colon carcinoma cell lines (K562 and HCT116), strongly suggesting that this new scaffold deserves further investigations for treatment of malignancies associated with Pim activity.

Knowledge Graph

Similar Paper

Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c
Bioorganic & Medicinal Chemistry 2016.0
Indolocarbazoles.3. Synthesis of novel aza analogs of staurosporine and K 252a as PKC inhibitors.
Bioorganic & Medicinal Chemistry Letters 1994.0
Production of the Staurosporine Aglycon K-252c with a Blocked Mutant of the Staurosporine Producer Strain Streptomyces longisporoflavus and by Biotransformation of Staurosporine with Streptomyces mediocidicus ATCC 13279.
The Journal of Antibiotics 1995.0
Indolocarbazoles. 1. Total synthesis and protein kinase inhibiting characteristics of compounds related to K-252c.
Bioorganic & Medicinal Chemistry Letters 1993.0
Synthesis and Mixed Lineage Kinase Activity of Pyrrolocarbazole and Isoindolone Analogs of (+)K-252a
Journal of Medicinal Chemistry 2007.0
Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides
Journal of Medicinal Chemistry 1992.0
Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles
Bioorganic & Medicinal Chemistry 2008.0
Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ
Bioorganic & Medicinal Chemistry Letters 2003.0
The Shurosporine Producing Strain Streptomyces longisporoflavus Produces Metabolites Related to K-252a. Proposal for Biosynthetic Intermediates of K-252a.
The Journal of Antibiotics 1996.0
Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors
Bioorganic & Medicinal Chemistry 2009.0